Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Hyoscine Butylbromide on Shortening of First and Second Stages of Labor

NCT02839213 is registered in ClinicalTrials.gov with Woman's Health University Hospital, Egypt as lead sponsor.

NCT NCT02839213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02839213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Hyoscine Butylbromide on Shortening of First and Second Stages of Labor
Lead sponsor
Woman's Health University Hospital, Egypt
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2015
Completion date
June 30, 2016
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

labor